Janssen seeks EMA approval for fixed-dose combination of HIV medicine darunavir with cobicistat

Janssen-Cilag (Janssen), a subsidiary of the Johnson & Johnson pharmaceutical firm, has filed a marketing authorisation application with the European Medicines Agency (EMA) for the approval of a once-daily fixed-dose antiretroviral combination tablet…
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news